BIO Commends the House of Representatives for Passing Stem Cell Research Enhancement Act.WASHINGTON -- Jim Greenwood, president and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of the Biotechnology Industry Organization Biotechnology Industry Organization or BIO was founded 1993 in Washington, DC. James C. Greenwood is BIO's current President. External links
"I commend Speaker Pelosi (D-CA), Representative DeGette (D-CO), Representative Castle (R-DE) and the members of both parties who voted for H.R. 3. More Members voted for this legislation than identical legislation last session, which demonstrates the progress we are making in educating Members and the people they represent about the great potential of embryonic stem cell Embryonic stem cells (ES cells) are stem cells derived from the inner cell mass of an early stage embryo known as a blastocyst. Human embryos reach the blastocyst stage 4-5 days post fertilization, at which time they consist of 50-150 cells. ES cells are pluripotent. research and the need to greatly enhance the ability of scientists to receive federal funding for this research. "While embryonic stem cell research is still at an early stage, the nation's top scientists agree that this technology has the greatest potential to provide new, groundbreaking therapies for diabetes, heart disease, spinal cord injuries Spinal Cord Injury Definition Spinal cord injury is damage to the spinal cord that causes loss of sensation and motor control. Description Approximately 10,000 new spinal cord injuries (SCIs) occur each year in the United States. and a host of other disabling and deadly conditions. We must do all we can to accelerate research and explore all avenues of therapeutic possibilities to their fullest. This bill allows important research to advance and creates an ethical framework to ensure that it is done appropriately. "H.R. 3 would expand the limited number of stem cell lines currently available for federally-funded research by allowing funds to be used for research on cell lines created from excess embryos from in vitro fertilization in vitro fertilization (vē`trō, vĭ`trō), technique for conception of a human embryo outside the mother's body. Several ova, or eggs, are removed from the mother's body and placed in special laboratory culture dishes (Petri dishes); clinics, regardless of when the cell lines were derived. These embryos are in excess of clinical need and would otherwise be discarded as medical waste. Individuals who choose to donate these embryos must give written consent and would not receive any monetary compensation for the donation. "I encourage Majority Leader Reid (D-NV) to move quickly to pass S. 5, the Senate companion to this legislation." BIO represents more than 1,100 biotechnology companies Top 100 Biotechnology Companies The following is a list of the top 100 biotechnology companies ranked by revenue. The first nine companies qualify for the list of the top 50 pharmaceutical companies. , academic institutions, state biotechnology centers and related organizations across the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area. and 31 other nations. BIO members are involved in the research and development of healthcare, agricultural, industrial and environmental biotechnology products. www.bio.org Upcoming Events -- BIO CEO & Investor Conference Feb. 12-14, 2007, New York City -- 2007 World Congress on Industrial Biotechnology and Bioprocessing March 21-24, 2007, Orlando, FL -- BIO International Convention May 6-9, 2007, Boston, MA |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion